TDs call on HSE Drugs Group to reveal why they decided not to fund Skyclarys
Craig Coady: 'I was actually gobsmacked; they basically said it wasn’t worth it — poor value for money — we’re talking about my child’s life, and I’ve already lost a child.' Picture: Chani Anderson
Politicians have called for “transparency” around the HSE Drugs Group decision not to recommend the drug Skyclarys, amid calls for the Oireachtas Health Committee to be recalled from its summer break.
Skyclarys is used to treat Friedreich’s ataxia, a rare genetic disorder that causes progressive damage to the nervous system and can lead to heart complications.
Politics
Newsletter
From the corridors of power to your inbox ... sign up for your essential weekly political briefing.




